| |
| |
|
| Insider
Information: |
Gosebruch Henry O |
| Relationship: |
|
| City: |
North Chicago |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
553,968 |
|
|
Indirect Shares
|
324,586 |
|
|
| Direct
Value |
$10,983,512 |
|
|
|
Indirect Value
|
$10,292,342 |
|
|
| Total
Shares |
878,554 |
|
|
| Total
Value |
$21,275,854 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
4
|
|
Stock
price went up :
|
1
|
3
|
| Stock
price went down : |
2
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
 -29.4%
|
 14.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abbvie Inc. |
ABBV |
EVP, Chief Strategy Of... |
2022-05-16 |
41,623 |
2022-05-16 |
57,138 |
Premium* |
|
|
Aptinyx Inc. |
APTX |
Director |
2019-10-04 |
0 |
2020-01-10 |
125,000 |
Premium* |
|
|
Acelyrin, Inc. |
SLRN |
Director |
2023-05-09 |
50,000 |
2023-05-09 |
0 |
Premium* |
|
|
Neumora Therapeutics, Inc. |
NMRA |
|
2024-02-14 |
462,345 |
2024-02-14 |
142,448 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
45 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABBV |
Abbvie Inc. |
Chief Strategy Officer |
• – – |
2015-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
91,050 |
91,050 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chief Strategy Officer |
• – – |
2016-12-09 |
4 |
D |
$60.90 |
$844,744 |
D/D |
(13,871) |
77,179 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chief Strategy Officer |
• – – |
2017-02-28 |
4 |
D |
$62.22 |
$1,286,274 |
D/D |
(20,673) |
101,737 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chief Strategy Officer |
• – – |
2017-07-31 |
4 |
S |
$70.37 |
$7,037 |
D/D |
(100) |
83,637 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chief Strategy Officer |
• – – |
2017-07-31 |
4 |
S |
$70.00 |
$1,261,638 |
D/D |
(18,000) |
83,737 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chief Strategy Officer |
• – – |
2017-07-31 |
4 |
S |
$70.45 |
$14,090 |
D/D |
(200) |
83,437 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chief Strategy Officer |
• – – |
2017-10-30 |
4 |
S |
$89.38 |
$1,657,037 |
D/D |
(18,300) |
65,137 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chief Strategy Officer |
• – – |
2017-12-09 |
4 |
D |
$95.95 |
$1,365,848 |
D/D |
(14,235) |
50,902 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
39,316 |
90,218 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2018-02-28 |
4 |
D |
$118.26 |
$2,059,853 |
D/D |
(17,418) |
72,800 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2018-11-29 |
4 |
S |
$90.10 |
$3,824,940 |
D/D |
(42,450) |
30,350 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2018-12-09 |
4 |
D |
$86.96 |
$1,169,264 |
D/D |
(13,446) |
16,904 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2019-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
51,815 |
68,719 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2019-02-28 |
4 |
D |
$79.41 |
$1,822,936 |
D/D |
(22,956) |
45,763 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2019-07-29 |
4 |
B |
$67.28 |
$2,018,385 |
D/D |
30,000 |
75,763 |
2.74 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2019-08-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
30,000 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2019-08-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
45,763 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
58,781 |
104,544 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2020-02-28 |
4 |
D |
$85.42 |
$2,224,166 |
D/D |
(26,038) |
78,506 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2020-04-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
18,500 |
48,500 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2020-04-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
18,500 |
60,006 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2020-11-20 |
4 |
S |
$98.83 |
$3,975,046 |
D/D |
(40,000) |
20,006 |
0 |
% |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
51,538 |
71,544 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2021-02-28 |
4 |
D |
$107.74 |
$2,460,027 |
D/D |
(22,833) |
48,711 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
EVP, Chief Strategy Officer |
• – – |
2021-09-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
78,500 |
0 |
- |
|
45 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
